Impact of responder definition on the enriched enrollment randomized withdrawal trial design for establishing proof of concept in neuropathic painDavid Hewitt, Hao Wang, Achilles Alon et al.|Pain|2010Cited by 63
The Pain Quality Response Profile of Pregabalin in the Treatment of Neuropathic PainMark P. Jensen, David Hewitt, Arnold R. Gammaitoni et al.|Clinical Journal of Pain|2011Cited by 18
Predicting Response to Pregabalin from Pretreatment Pain Quality: Clinical Applications of the Pain Quality Assessment ScaleArnold R. Gammaitoni, David Hewitt, Steven S. Smugar et al.|Pain Medicine|2012Cited by 16
The potential of the Enriched Enrollment Randomized Withdrawal (EERW) paradigm for proof of concept studies of novel agents for the treatment of neuropathic pain (NP)David Hewitt, David Kudrow, H. Wang et al.|Journal of Pain|2009Cited by 2